Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
Maria Rescigno, Chiara Agrati, Carlo Salvarani, Diana Giannarelli, Massimo Costantini, Alberto Mantovani, Raffaella Massafra, Pier Luigi Zinzani, Aldo Morrone, Stefania Notari, Giulia Matusali, View ORCID ProfileGiuseppe Lauria Pinter, Antonio Uccelli, Gennaro Ciliberto, Fausto Baldanti, Franco Locatelli, Nicola Silvestris, Valentina Sinno, Elena Turola, VAX4FRAIL study Group, Maria Teresa Lupo Stanghellini, Giovanni Apolone
doi: https://doi.org/10.1101/2022.11.19.22282537
Maria Rescigno
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
2Mucosal Immunology and Microbiota Unit, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
Chiara Agrati
3Cellular Immunology Laboratory, INMI L Spallanzani, Roma
4Department of Hematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children Hospital, Roma
Carlo Salvarani
5Unità di Reumatologia, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia
6Unità di Reumatologia, Università degli Studi di Modena e Reggio Emilia, Reggio Emilia
Diana Giannarelli
7Facility di Epidemiologia e Biostatistica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma
Massimo Costantini
8Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Alberto Mantovani
9Humanitas Scientific Directorate, IRCCS Humanitas, Clinical and Research Center, Rozzano
10Department of Biomedical Sciences, Humanitas University, Milano
11William Harvey Research Institute, Queen Mary University, London, United Kingdom
Raffaella Massafra
12Vice Scientific Directorate, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari
Pier Luigi Zinzani
13IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”
14Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna
Aldo Morrone
15Scientific Directorate, San Gallicano Dermatological Institute IRCCS, Roma
Stefania Notari
16Cellular Immunology Laboratory, National Institute for Infectious Diseases L Spallanzani–IRCCS, Roma
Giulia Matusali
17Virology Laboratory, National Institute for Infectious Diseases L Spallanzani–IRCCS, Roma
Giuseppe Lauria Pinter
18Scientific Directorate, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano
19Department of Medical Biotechnology and Translational Medicine, University of Milan, Milano
Antonio Uccelli
20Scientific Directorate, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genoa
21Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa
Gennaro Ciliberto
22Scientific Directorate, IRCCS Regina Elena, National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Roma
Fausto Baldanti
23Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia
24Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia
Franco Locatelli
25Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, IRCCS, Bambino Gesù Children Hospital, Roma
26Department of Pediatrics, Catholic University of the Sacred Heart, Roma
Nicola Silvestris
27Medical Oncology Unit, Department of Human Pathology “G. Barresi”, University of Messina, Messina
Valentina Sinno
28Department of Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Elena Turola
29Infrastruttura Ricerca e Statistica, Azienda USL-IRCCS, Reggio Emilia
30Hematology and BMT Unit, IRCCS Ospedale San Raffaele, Milano
Giovanni Apolone
8Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Posted November 19, 2022.
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
Maria Rescigno, Chiara Agrati, Carlo Salvarani, Diana Giannarelli, Massimo Costantini, Alberto Mantovani, Raffaella Massafra, Pier Luigi Zinzani, Aldo Morrone, Stefania Notari, Giulia Matusali, Giuseppe Lauria Pinter, Antonio Uccelli, Gennaro Ciliberto, Fausto Baldanti, Franco Locatelli, Nicola Silvestris, Valentina Sinno, Elena Turola, VAX4FRAIL study Group, Maria Teresa Lupo Stanghellini, Giovanni Apolone
medRxiv 2022.11.19.22282537; doi: https://doi.org/10.1101/2022.11.19.22282537
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
Maria Rescigno, Chiara Agrati, Carlo Salvarani, Diana Giannarelli, Massimo Costantini, Alberto Mantovani, Raffaella Massafra, Pier Luigi Zinzani, Aldo Morrone, Stefania Notari, Giulia Matusali, Giuseppe Lauria Pinter, Antonio Uccelli, Gennaro Ciliberto, Fausto Baldanti, Franco Locatelli, Nicola Silvestris, Valentina Sinno, Elena Turola, VAX4FRAIL study Group, Maria Teresa Lupo Stanghellini, Giovanni Apolone
medRxiv 2022.11.19.22282537; doi: https://doi.org/10.1101/2022.11.19.22282537
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)